IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

OUP Management Co., LLC

Q1 2022 Holdings

Filed 2022-05-04 | 16 holdings | $131.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ionQ, Inc.(IONQ)Common Stock46222L108$29.6K2,319,51922.5%
Centessa Pharmaceuticals plc(CNTA)Sponsored ADS152309100$26.4K2,937,61520.1%
PMV Pharmaceuticals, Inc.(PMVP)Common Stock69353Y103$20.6K989,23215.7%
Aerovate Therapeutics Inc.Common Stock008064107$11.1K603,7628.4%
Dice Therapeutics Inc.Common Stock23345J104$10.3K536,6937.8%
Cyteir Therapeutics, Inc.Common Stock23284P103$9.3K2,474,5727.1%
Evolv Technologies Holdings, Inc.(EVLV)Common Stock30049H102$4.8K1,820,8663.7%
eFFECTOR Therapeutics, Inc.Common Stock28202V108$4.1K1,025,6973.1%
Precision BioSciences, Inc.Common Stock74019P108$3.5K1,123,9132.6%
Landos Biopharma, Inc.Common Stock515069102$2.7K1,827,4782.1%
Vor Biopharma Inc.Common Stock929033108$2.3K374,7141.7%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$2.2K249,0701.6%
Graphite Bio(GRPH)Common Stock38870X104$2.1K406,3081.6%
Sera Prognostics, Inc.(SERA)Common Stock81749D107$1.3K337,5051.0%
Selecta Biosciences, Inc.(SELBUSD)Common Stock816212104$1.1K862,5430.8%
Homology Medicines, Inc.Common Stock438083107$19564,0000.1%